(Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide

C158H152F24N42O17 — CID 158614510

About (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide

(Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide (PubChem CID 158614510) has the molecular formula C158H152F24N42O17 and a molecular weight of 3367.18 g/mol. Its IUPAC name is (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide.

Molecular Properties

• Compound Name: (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide
• PubChem CID: 158614510
• Molecular Formula: C158H152F24N42O17
• Molecular Weight: 3367.18 g/mol
• Exact Mass: 3365.19
• IUPAC Name: (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide
• SMILES: CC(=O)N1CCC2(CC1)CCN(NC(=O)/C=C\n1cnc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n1)C2=O.CN1CC2(CCN(NC(=O)/C=C\n3cnc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)C2=O)C1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@@H]4C=C[C@H]3C4)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@@H]4CC[C@H]3C4)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@H]4C=C[C@@H]3C4)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@H]4CC[C@@H]3C4)n2)c1.O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NN1CC2CCCCC2C1=O.O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NN1C[C@H]2C[C@H]2C1=O
• InChI: InChI=1S/C23H22F6N6O3.C21H19F6N5O2.C20H18F6N6O2.2C19H21N5O2.2C19H19N5O2.C18H13F6N5O2/c1-14(36)33-7-3-21(4-8-33)5-9-35(20(21)38)31-18(37)2-6-34-13-30-19(32-34)15-10-16(22(24,25)26)12-17(11-15)23(27,28)29;22-20(23,24)14-7-13(8-15(9-14)21(25,26)27)18-28-11-31(30-18)6-5-17(33)29-32-10-12-3-1-2-4-16(12)19(32)34;1-30-9-18(10-30)3-5-32(17(18)34)28-15(33)2-4-31-11-27-16(29-31)12-6-13(19(21,22)23)8-14(7-12)20(24,25)26;4*1-12-7-13(2)9-15(8-12)18-20-11-23(22-18)6-5-17(25)21-24-16-4-3-14(10-16)19(24)26;19-17(20,21)11-3-9(4-12(6-11)18(22,23)24)15-25-8-28(27-15)2-1-14(30)26-29-7-10-5-13(10)16(29)31/h2,6,10-13H,3-5,7-9H2,1H3,(H,31,37);5-9,11-12,16H,1-4,10H2,(H,29,33);2,4,6-8,11H,3,5,9-10H2,1H3,(H,28,33);2*5-9,11,14,16H,3-4,10H2,1-2H3,(H,21,25);2*3-9,11,14,16H,10H2,1-2H3,(H,21,25);1-4,6,8,10,13H,5,7H2,(H,26,30)/b6-2-;6-5-;4-2-;4*6-5-;2-1-/t;;;4*14-,16+;10-,13-/m...10101/s1
• InChIKey: HXFNSJHHGMAQJO-CJCJCJMXSA-N
• XLogP: 20.94
• TPSA: 664.51 Ų
• H-Bond Donors: 8
• H-Bond Acceptors: 42
• Rotatable Bonds: 32
• Heavy Atoms: 241
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3367.18
LogP ≤ 5	20.94
H-Bond Donors ≤ 5	8
H-Bond Acceptors ≤ 10	42

Frequently Asked Questions

What is the IUPAC name of (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide?

The IUPAC name of (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide (CID 158614510) is (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide.

What is the SMILES notation for (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide?

The canonical SMILES for (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide is CC(=O)N1CCC2(CC1)CCN(NC(=O)/C=C\n1cnc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n1)C2=O.CN1CC2(CCN(NC(=O)/C=C\n3cnc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)C2=O)C1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@@H]4C=C[C@H]3C4)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@@H]4CC[C@H]3C4)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@H]4C=C[C@@H]3C4)n2)c1.Cc1cc(C)cc(-c2ncn(/C=C\C(=O)NN3C(=O)[C@H]4CC[C@@H]3C4)n2)c1.O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NN1CC2CCCCC2C1=O.O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NN1C[C@H]2C[C@H]2C1=O.

What is the InChIKey of (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide?

The InChIKey is HXFNSJHHGMAQJO-CJCJCJMXSA-N. The full InChI is InChI=1S/C23H22F6N6O3.C21H19F6N5O2.C20H18F6N6O2.2C19H21N5O2.2C19H19N5O2.C18H13F6N5O2/c1-14(36)33-7-3-21(4-8-33)5-9-35(20(21)38)31-18(37)2-6-34-13-30-19(32-34)15-10-16(22(24,25)26)12-17(11-15)23(27,28)29;22-20(23,24)14-7-13(8-15(9-14)21(25,26)27)18-28-11-31(30-18)6-5-17(33)29-32-10-12-3-1-2-4-16(12)19(32)34;1-30-9-18(10-30)3-5-32(17(18)34)28-15(33)2-4-31-11-27-16(29-31)12-6-13(19(21,22)23)8-14(7-12)20(24,25)26;4*1-12-7-13(2)9-15(8-12)18-20-11-23(22-18)6-5-17(25)21-24-16-4-3-14(10-16)19(24)26;19-17(20,21)11-3-9(4-12(6-11)18(22,23)24)15-25-8-28(27-15)2-1-14(30)26-29-7-10-5-13(10)16(29)31/h2,6,10-13H,3-5,7-9H2,1H3,(H,31,37);5-9,11-12,16H,1-4,10H2,(H,29,33);2,4,6-8,11H,3,5,9-10H2,1H3,(H,28,33);2*5-9,11,14,16H,3-4,10H2,1-2H3,(H,21,25);2*3-9,11,14,16H,10H2,1-2H3,(H,21,25);1-4,6,8,10,13H,5,7H2,(H,26,30)/b6-2-;6-5-;4-2-;4*6-5-;2-1-/t;;;4*14-,16+;10-,13-/m...10101/s1.

What are the key properties of (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide?

(Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide has a molecular weight of 3367.18 g/mol, XLogP of 20.94, 32 rotatable bonds, 8 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for (Z)-N-(8-acetyl-1-oxo-2,8-diazaspiro[4.5]decan-2-yl)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(2-methyl-5-oxo-2,6-diazaspiro[3.4]octan-6-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-(3-oxo-3a,4,5,6,7,7a-hexahydro-1H-isoindol-2-yl)prop-2-enamide;(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N-[(1R,5S)-2-oxo-3-azabicyclo[3.1.0]hexan-3-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]heptan-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1R,4S)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide;(Z)-3-[3-(3,5-dimethylphenyl)-1,2,4-triazol-1-yl]-N-[(1S,4R)-3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl]prop-2-enamide is sourced from PubChem (CID 158614510), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).